TETRAPHASE Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TETRAPHASE, and when can generic versions of TETRAPHASE drugs launch?
TETRAPHASE has one approved drug.
There are four US patents protecting TETRAPHASE drugs.
There are seventy-one patent family members on TETRAPHASE drugs in thirty-three countries and seventeen supplementary protection certificates in fifteen countries.
Drugs and US Patents for TETRAPHASE
International Patents for TETRAPHASE Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 2018075767 | ⤷ Try a Trial |
Croatia | P20151368 | ⤷ Try a Trial |
Portugal | 2323972 | ⤷ Try a Trial |
Cyprus | 1114689 | ⤷ Try a Trial |
Israel | 231954 | ⤷ Try a Trial |
Canada | 2732883 | ⤷ Try a Trial |
Argentina | 072990 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for TETRAPHASE Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2323972 | 1990014-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/18/1312 20180924 |
2323972 | 2019C/511 | Belgium | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/18/1312 20180924 |
2323972 | 19C1012 | France | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/18/1312 20180924 |
2323972 | 300971 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: ERAVACYCLINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/18/1312 20180924 |
2323972 | 715 | Finland | ⤷ Try a Trial | |
2323972 | PA2019009 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: ERAVACIKLINAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/18/1312 C(2018)6231 20180920 |
2323972 | C20190009 00277 | Estonia | ⤷ Try a Trial | PRODUCT NAME: ERAVATSUEKLIIN;REG NO/DATE: EU/1/18/1312 24.09.2018 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.